Skip to main content

Table 2 Mean annual exacerbation rate per patient year in the 12 months post-index date by covariate

From: The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA

 

US database

(N = 222,817)

Rate (95% CI)

UK database

(N = 211,807)

Rate (95% CI)

Overall

0.161 (0.159, 0.163)

0.110 (0.109, 0.111)

GINA Step

Step 1

0.139 (0.136, 0.142)

0.066 (0.063, 0.069)

Step 2

0.143 (0.138, 0.147)

0.070 (0.067, 0.073)

Step 3

0.153 (0.148, 0.158)

0.086 (0.084, 0.089)

Step 4

0.186 (0.181, 0.191)

0.126 (0.123, 0.130)

Step 5

0.455 (0.434, 0.478)

0.512 (0.490, 0.536)

Not classifiable/none

0.105 (0.078, 0.142)

0.113 (0.084, 0.150)

Exacerbations during the 12-month pre-index period

0

0.110 (0.109, 0.112)

0.070 (0.069, 0.071)

1

0.308 (0.301, 0.315)

0.273 (0.265, 0.282)

2

0.674 (0.638, 0.712)

0.644 (0.601, 0.690)

3

1.150 (1.036, 1.276)

1.236 (1.080, 1.414)

≥4

2.195 (1.925, 2.504)

2.687 (2.269, 3.183)

Severe uncontrolled asthmaa

Yes

1.016 (0.939, 1.099)

1.088 (1.002, 1.181)

No

0.153 (0.151, 0.155)

0.098 (0.096, 0.100)

Severe uncontrolled eosinophilic asthmab

Yes

1.158 (0.828, 1.619)

1.389 (1.127, 1.712)

No

0.153 (0.148, 0.159)

0.132 (0.128, 0.136)

  1. aDefined as patients at GINA Step 4 or 5 with ≥2 exacerbations in the previous 12 months; bpatients with severe uncontrolled asthma criteria and blood eosinophil counts ≥300 cells/μl at baseline. CI confidence interval, GINA Global Initiative for Asthma